These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 32017990)
1. The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy. Coppa A; Guha S; Fourcade S; Parameswaran J; Ruiz M; Moser AB; Schlüter A; Murphy MP; Lizcano JM; Miranda-Vizuete A; Dalfó E; Pujol A Free Radic Biol Med; 2020 May; 152():797-809. PubMed ID: 32017990 [TBL] [Abstract][Full Text] [Related]
2. Anti-oxidant MitoQ rescue of AWB chemosensory neuron impairment in a Guha S; Pujol A; Dalfo E MicroPubl Biol; 2021 Jan; 2021():. PubMed ID: 33474532 [TBL] [Abstract][Full Text] [Related]
3. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy. Baarine M; Beeson C; Singh A; Singh I J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703 [TBL] [Abstract][Full Text] [Related]
4. Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy. Morató L; Galino J; Ruiz M; Calingasan NY; Starkov AA; Dumont M; Naudí A; Martínez JJ; Aubourg P; Portero-Otín M; Pamplona R; Galea E; Beal MF; Ferrer I; Fourcade S; Pujol A Brain; 2013 Aug; 136(Pt 8):2432-43. PubMed ID: 23794606 [TBL] [Abstract][Full Text] [Related]
6. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction. Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276 [TBL] [Abstract][Full Text] [Related]
7. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy. Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971 [TBL] [Abstract][Full Text] [Related]
8. Imbalanced mitochondrial dynamics contributes to the pathogenesis of X-linked adrenoleukodystrophy. Launay N; Lopez-Erauskin J; Bianchi P; Guha S; Parameswaran J; Coppa A; Torreni L; Schlüter A; Fourcade S; Paredes-Fuentes AJ; Artuch R; Casasnovas C; Ruiz M; Pujol A Brain; 2024 Jun; 147(6):2069-2084. PubMed ID: 38763511 [TBL] [Abstract][Full Text] [Related]
9. Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy. Ranea-Robles P; Launay N; Ruiz M; Calingasan NY; Dumont M; Naudí A; Portero-Otín M; Pamplona R; Ferrer I; Beal MF; Fourcade S; Pujol A EMBO Mol Med; 2018 Aug; 10(8):. PubMed ID: 29997171 [TBL] [Abstract][Full Text] [Related]
11. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes. Singh J; Khan M; Singh I J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797 [TBL] [Abstract][Full Text] [Related]
12. Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions. Kruska N; Schönfeld P; Pujol A; Reiser G Biochim Biophys Acta; 2015 May; 1852(5):925-36. PubMed ID: 25583114 [TBL] [Abstract][Full Text] [Related]
13. Beneficial Effects of the Direct AMP-Kinase Activator PXL770 in In Vitro and In Vivo Models of X-Linked Adrenoleukodystrophy. Monternier PA; Parasar P; Theurey P; Gluais Dagorn P; Kaur N; Nagaraja TN; Fouqueray P; Bolze S; Moller DE; Singh J; Hallakou-Bozec S J Pharmacol Exp Ther; 2022 Aug; 382(2):208-222. PubMed ID: 35764327 [TBL] [Abstract][Full Text] [Related]
14. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy. Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332 [TBL] [Abstract][Full Text] [Related]
15. Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy. Raas Q; van de Beek MC; Forss-Petter S; Dijkstra IM; Deschiffart A; Freshner BC; Stevenson TJ; Jaspers YR; Nagtzaam L; Wanders RJ; van Weeghel M; Engelen-Lee JY; Engelen M; Eichler F; Berger J; Bonkowsky JL; Kemp S J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690217 [TBL] [Abstract][Full Text] [Related]
16. Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy. Nemeth CL; Gӧk Ö; Tomlinson SN; Sharma A; Moser AB; Kannan S; Kannan RM; Fatemi A Neurotherapeutics; 2023 Jan; 20(1):272-283. PubMed ID: 36207570 [TBL] [Abstract][Full Text] [Related]